Mcl‐1 and Bcl‐xL levels predict responsiveness to dual MEK/Bcl‐2 inhibition in B‐cell malignancies
Katrine Melvold(Oslo University Hospital), Sigrid S. Skånland(Oslo University Hospital)
Cited by 16
Related Papers
Phosphoinositide‐Regulated Retrograde Transport of Ricin: Crosstalk Between hVps34 and Sorting Nexins
|Traffic|2006|60
A tumor microenvironment model of chronic lymphocytic leukemia enables drug sensitivity testing to guide precision medicine
|Cell Death Discovery|2023|17
Standardized assays to monitor drug sensitivity in hematologic cancers
|Cell Death Discovery|2023|17